Top Markets
#1 Glidr Glidr +51.75%
#2 Akedo Akedo +51.75%
#3 DOVU DOVU +48.15%
#4 Black Phoenix Black Phoenix +34.08%
#5 Velvet Velvet +33.34%
#6 Cross Cross +29.27%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.47%
#8 OVERTAKE OVERTAKE +15.82%
#9 Bitway Bitway +15.10%
#10 QANplatform QANplatform +14.50%
Coin of the day
Glidr Glidr
Settings
Language
ENGLISH
Currency
USD
Theme
Vivanza Biosciences Limited Vivanza Biosciences Limited

Vivanza Biosciences Limited

VIVANZA
Rank in Stocks #38721
Vivanza Biosciences Limited is a pharmaceutical firm specializing in the... Vivanza Biosciences Limited is a pharmaceutical firm specializing in the creation and commercialization of medicinal products. Among its offerings, the company prominently features Intravenous (IV) Fusion solutions. This enterprise was founded on March 3, 1982, and maintains its primary operational base in Ahmedabad, India.
Share Price
$0.02096817
Market Cap
$838.73K
Change (1 day)
-4.52%
Change (1 year)
-12.44%
Country
IN
Trade Vivanza Biosciences Limited (VIVANZA)

Category

Healthcare
Earnings for Vivanza Biosciences Limited (VIVANZA)
Earnings in 2026 TTM: 0
According to Vivanza Biosciences Limited latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Vivanza Biosciences Limited from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US